113 related articles for article (PubMed ID: 21129817)
1. High level cephalosporin-resistant Enterobacteriaceae ventilator-associated pneumonia: prognostic factors based on a cohort study.
Aubron C; Chaari A; Bronchard R; Armand-Lefèvre L; Montravers P; Régnier B; Wolff M; Lucet JC
J Hosp Infect; 2011 Jan; 77(1):64-9. PubMed ID: 21129817
[TBL] [Abstract][Full Text] [Related]
2. Ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae carrying multiple metallo-beta-lactamase genes.
Dwivedi M; Mishra A; Azim A; Singh RK; Baronia AK; Prasad KN; Dhole TN; Dwivedi UN
Indian J Pathol Microbiol; 2009; 52(3):339-42. PubMed ID: 19679955
[TBL] [Abstract][Full Text] [Related]
3. Assessment of five screening strategies for optimal detection of carriers of third-generation cephalosporin-resistant Enterobacteriaceae in intensive care units using daily sampling.
Grohs P; Podglajen I; Guerot E; Bellenfant F; Caumont-Prim A; Kac G; Tillecovidin B; Carbonnelle E; Chatellier G; Meyer G; Fagon JY; Gutmann L
Clin Microbiol Infect; 2014 Nov; 20(11):O879-86. PubMed ID: 24807791
[TBL] [Abstract][Full Text] [Related]
4. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
6. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
Thiébaut AC; Arlet G; Andremont A; Papy E; Sollet JP; Bernède-Bauduin C; Guillemot D; Schlemmer B;
J Antimicrob Chemother; 2012 Jun; 67(6):1525-36. PubMed ID: 22441577
[TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England.
Potz NA; Hope R; Warner M; Johnson AP; Livermore DM;
J Antimicrob Chemother; 2006 Aug; 58(2):320-6. PubMed ID: 16735428
[TBL] [Abstract][Full Text] [Related]
9. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia.
Agbaht K; Diaz E; Muñoz E; Lisboa T; Gomez F; Depuydt PO; Blot SI; Rello J
Crit Care Med; 2007 Sep; 35(9):2064-70. PubMed ID: 17581489
[TBL] [Abstract][Full Text] [Related]
10. The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae.
Tamma PD; Girdwood SC; Gopaul R; Tekle T; Roberts AA; Harris AD; Cosgrove SE; Carroll KC
Clin Infect Dis; 2013 Sep; 57(6):781-8. PubMed ID: 23759352
[TBL] [Abstract][Full Text] [Related]
11. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
12. Ventilator-associated pneumonia in trauma patients is associated with lower mortality: results from EU-VAP study.
Magret M; Amaya-Villar R; Garnacho J; Lisboa T; Díaz E; Dewaele J; Deja M; Manno E; Rello J;
J Trauma; 2010 Oct; 69(4):849-54. PubMed ID: 20938271
[TBL] [Abstract][Full Text] [Related]
13. Decontamination of cephalosporin-resistant Enterobacteriaceae during selective digestive tract decontamination in intensive care units.
Oostdijk EA; de Smet AM; Kesecioglu J; Bonten MJ;
J Antimicrob Chemother; 2012 Sep; 67(9):2250-3. PubMed ID: 22643189
[TBL] [Abstract][Full Text] [Related]
14. Five-year trends for ventilator-associated pneumonia: Correlation between microbiological findings and antimicrobial drug consumption.
Fihman V; Messika J; Hajage D; Tournier V; Gaudry S; Magdoud F; Barnaud G; Billard-Pomares T; Branger C; Dreyfuss D; Ricard JD
Int J Antimicrob Agents; 2015 Nov; 46(5):518-25. PubMed ID: 26358970
[TBL] [Abstract][Full Text] [Related]
15. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
Shorr AF; Combes A; Kollef MH; Chastre J
Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of ertapenem in the treatment of early ventilator-associated pneumonia caused by extended-spectrum beta-lactamase-producing organisms in an intensive care unit.
Bassetti M; Righi E; Fasce R; Molinari MP; Rosso R; Di Biagio A; Mussap M; Pallavicini FB; Viscoli C
J Antimicrob Chemother; 2007 Aug; 60(2):433-5. PubMed ID: 17540673
[TBL] [Abstract][Full Text] [Related]
17. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.
Eagye KJ; Nicolau DP; Kuti JL
Semin Respir Crit Care Med; 2009 Feb; 30(1):116-23. PubMed ID: 19199193
[TBL] [Abstract][Full Text] [Related]
18. Significance of Prior Digestive Colonization With Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Patients With Ventilator-Associated Pneumonia.
Bruyère R; Vigneron C; Bador J; Aho S; Toitot A; Quenot JP; Prin S; Charles PE
Crit Care Med; 2016 Apr; 44(4):699-706. PubMed ID: 26571186
[TBL] [Abstract][Full Text] [Related]
19. Resistance in gram-negative bacteria: enterobacteriaceae.
Paterson DL
Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
[TBL] [Abstract][Full Text] [Related]
20. High rates of antimicrobial co-resistance among Enterobacteriaceae: comparative analysis between clinical isolates resistant and susceptible to third-generation cephalosporins.
Goyanes MJ; Cercenado E; Insa R; Morente A; Alcalá L; Bouza E
Rev Esp Quimioter; 2007 Jun; 20(2):216-21. PubMed ID: 17893759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
